Global Tetanus Toxoid Vaccine Market by Vaccine Type (Diphtheria and Tetanus (DT), Diphtheria,Tetanus, and Pertussis (DTaP), Tetanus, Diphtheria and Pertussis (Tdap)), Age (Adults, Neonatal), End User - Forecast 2024-2030- Product Image

Sale

Global Tetanus Toxoid Vaccine Market by Vaccine Type (Diphtheria and Tetanus (DT), Diphtheria,Tetanus, and Pertussis (DTaP), Tetanus, Diphtheria and Pertussis (Tdap)), Age (Adults, Neonatal), End User - Forecast 2024-2030

Report
197 Pages
March 2024
Region: Global
360iResearch™
ID: 5790382

UP TO €846EUR$875USD£727GBP OFF until Dec 31^st 2024

The Tetanus Toxoid Vaccine Market size was estimated at USD 5.58 billion in 2023, USD 5.86 billion in 2024, and is expected to grow at a CAGR of 6.75% to reach USD 8.83 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Tetanus Toxoid Vaccine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Tetanus Toxoid Vaccine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Tetanus Toxoid Vaccine Market, highlighting leading vendors and their innovative profiles. These include AJ Vaccines A/S, Astellas Pharma Inc., BB-NCIPD Ltd., Bharat Biotech Ltd., Bio Farma, Biological E. Limited, Dano Vaccines & Biologicals Pvt. Ltd., GlaxoSmithKline PLC, Haffkine Bio-Pharmaceutical Corporation Ltd., Incepta Vaccine Ltd., MEDZEEL LIFESCIENCE, Merck & Co, Inc., Panacea Biotec Limited, Pfizer Inc., Sanofi S.A., and Takeda Pharmaceutical Company Limited.

Market Segmentation & Coverage

This research report categorizes the Tetanus Toxoid Vaccine Market to forecast the revenues and analyze trends in each of the following sub-markets:

Vaccine Type
- Diphtheria and Tetanus (DT)
- Diphtheria,Tetanus, and Pertussis (DTaP)
- Tetanus, Diphtheria and Pertussis (Tdap)
Age
- Adults
- Neonatal
End User
- Clinics
- Hospitals

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Tetanus Toxoid Vaccine Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Tetanus Toxoid Vaccine Market?
What are the technology trends and regulatory frameworks in the Tetanus Toxoid Vaccine Market?
What is the market share of the leading vendors in the Tetanus Toxoid Vaccine Market?
Which modes and strategic moves are suitable for entering the Tetanus Toxoid Vaccine Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Tetanus Toxoid Vaccine Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Significant prevalence of tetanus worldwide
5.1.1.2. Low cost and wide availability of tetanus vaccine
5.1.2. Restraints
5.1.2.1. Potential product recall due to vaccine quality defects
5.1.3. Opportunities
5.1.3.1. Government initiatives for awareness and immunization programs
5.1.3.2. Improving cold chain and healthcare infrastructure across countries
5.1.4. Challenges
5.1.4.1. Side effects associated with vaccine
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Tetanus Toxoid Vaccine Market, by Vaccine Type

6.1. Introduction
6.2. Diphtheria and Tetanus (DT)
6.3. Diphtheria,Tetanus, and Pertussis (DTaP)
6.4. Tetanus, Diphtheria and Pertussis (Tdap)

7. Tetanus Toxoid Vaccine Market, by Age

7.1. Introduction
7.2. Adults
7.3. Neonatal

8. Tetanus Toxoid Vaccine Market, by End User

8.1. Introduction
8.2. Clinics
8.3. Hospitals

9. Americas Tetanus Toxoid Vaccine Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Tetanus Toxoid Vaccine Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Tetanus Toxoid Vaccine Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
13.1.1. AJ Vaccines A/S
13.1.2. Astellas Pharma Inc.
13.1.3. BB-NCIPD Ltd.
13.1.4. Bharat Biotech Ltd.
13.1.5. Bio Farma
13.1.6. Biological E. Limited
13.1.7. Dano Vaccines & Biologicals Pvt. Ltd.
13.1.8. GlaxoSmithKline PLC
13.1.9. Haffkine Bio-Pharmaceutical Corporation Ltd.
13.1.10. Incepta Vaccine Ltd.
13.1.11. MEDZEEL LIFESCIENCE
13.1.12. Merck & Co, Inc.
13.1.13. Panacea Biotec Limited
13.1.14. Pfizer Inc.
13.1.15. Sanofi S.A.
13.1.16. Takeda Pharmaceutical Company Limited
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. TETANUS TOXOID VACCINE MARKET RESEARCH PROCESS
FIGURE 2. TETANUS TOXOID VACCINE MARKET SIZE, 2023 VS 2030
FIGURE 3. TETANUS TOXOID VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. TETANUS TOXOID VACCINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. TETANUS TOXOID VACCINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. TETANUS TOXOID VACCINE MARKET DYNAMICS
FIGURE 7. TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2023 VS 2030 (%)
FIGURE 8. TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2023 VS 2030 (%)
FIGURE 10. TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 12. TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS TETANUS TOXOID VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS TETANUS TOXOID VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES TETANUS TOXOID VACCINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES TETANUS TOXOID VACCINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC TETANUS TOXOID VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC TETANUS TOXOID VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TETANUS TOXOID VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TETANUS TOXOID VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. TETANUS TOXOID VACCINE MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. TETANUS TOXOID VACCINE MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. TETANUS TOXOID VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. TETANUS TOXOID VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TETANUS TOXOID VACCINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 6. TETANUS TOXOID VACCINE MARKET SIZE, BY DIPHTHERIA AND TETANUS (DT), BY REGION, 2018-2030 (USD MILLION)
TABLE 7. TETANUS TOXOID VACCINE MARKET SIZE, BY DIPHTHERIA,TETANUS, AND PERTUSSIS (DTAP), BY REGION, 2018-2030 (USD MILLION)
TABLE 8. TETANUS TOXOID VACCINE MARKET SIZE, BY TETANUS, DIPHTHERIA AND PERTUSSIS (TDAP), BY REGION, 2018-2030 (USD MILLION)
TABLE 9. TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 10. TETANUS TOXOID VACCINE MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. TETANUS TOXOID VACCINE MARKET SIZE, BY NEONATAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 13. TETANUS TOXOID VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. TETANUS TOXOID VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS TETANUS TOXOID VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 19. ARGENTINA TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 20. ARGENTINA TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 22. BRAZIL TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 23. BRAZIL TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 25. CANADA TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 26. CANADA TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 27. CANADA TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 28. MEXICO TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 29. MEXICO TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 30. MEXICO TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES TETANUS TOXOID VACCINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 35. ASIA-PACIFIC TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 36. ASIA-PACIFIC TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC TETANUS TOXOID VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 39. AUSTRALIA TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 40. AUSTRALIA TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. CHINA TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 43. CHINA TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 44. CHINA TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. INDIA TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 46. INDIA TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 47. INDIA TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. INDONESIA TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 49. INDONESIA TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. JAPAN TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 52. JAPAN TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 53. JAPAN TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. MALAYSIA TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 55. MALAYSIA TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. PHILIPPINES TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 58. PHILIPPINES TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. SINGAPORE TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 61. SINGAPORE TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. SOUTH KOREA TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 64. SOUTH KOREA TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. TAIWAN TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 67. TAIWAN TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. THAILAND TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 70. THAILAND TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 71. THAILAND TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. VIETNAM TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 73. VIETNAM TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA TETANUS TOXOID VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 79. DENMARK TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 80. DENMARK TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 81. DENMARK TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. EGYPT TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 83. EGYPT TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 84. EGYPT TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. FINLAND TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 86. FINLAND TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 87. FINLAND TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. FRANCE TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 89. FRANCE TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 90. FRANCE TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. GERMANY TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 92. GERMANY TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 93. GERMANY TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. ISRAEL TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 95. ISRAEL TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. ITALY TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 98. ITALY TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 99. ITALY TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. NETHERLANDS TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 101. NETHERLANDS TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. NIGERIA TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 104. NIGERIA TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. NORWAY TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 107. NORWAY TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 108. NORWAY TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. POLAND TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 110. POLAND TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 111. POLAND TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. QATAR TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 113. QATAR TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 114. QATAR TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. RUSSIA TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. SAUDI ARABIA TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. SOUTH AFRICA TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 122. SOUTH AFRICA TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. SPAIN TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 125. SPAIN TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 126. SPAIN TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. SWEDEN TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 128. SWEDEN TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. SWITZERLAND TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 131. SWITZERLAND TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. TURKEY TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 134. TURKEY TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 135. TURKEY TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. UNITED ARAB EMIRATES TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 137. UNITED ARAB EMIRATES TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM TETANUS TOXOID VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM TETANUS TOXOID VACCINE MARKET SIZE, BY AGE, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM TETANUS TOXOID VACCINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. TETANUS TOXOID VACCINE MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 143. TETANUS TOXOID VACCINE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 144. TETANUS TOXOID VACCINE MARKET LICENSE & PRICING

Companies Mentioned

AJ Vaccines A/S
Astellas Pharma Inc.
BB-NCIPD Ltd.
Bharat Biotech Ltd.
Bio Farma
Biological E. Limited
Dano Vaccines & Biologicals Pvt. Ltd.
GlaxoSmithKline PLC
Haffkine Bio-Pharmaceutical Corporation Ltd.
Incepta Vaccine Ltd.
MEDZEEL LIFESCIENCE
Merck & Co, Inc.
Panacea Biotec Limited
Pfizer Inc.
Sanofi S.A.
Takeda Pharmaceutical Company Limited

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	197
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 5.86 Billion
Forecasted Market Value ( USD ) by 2030	$ 8.83 Billion
Compound Annual Growth Rate	6.7%
Regions Covered	Global
No. of Companies Mentioned	16

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3262EUR$3,374USD£2,804GBP €3624EUR$3,749USD£3,115GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4132EUR$4,274USD£3,551GBP €4591EUR$4,749USD£3,946GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5002EUR$5,174USD£4,299GBP €5558EUR$5,749USD£4,777GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5872EUR$6,074USD£5,047GBP €6524EUR$6,749USD£5,608GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7612EUR$7,874USD£6,543GBP €8458EUR$8,749USD£7,270GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Tetanus Toxoid Vaccine Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

Toxoid Vaccine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

Global Markets for Vaccine Technologies

The World Market for Vaccines, 2024

Pertussis Vaccine Global Market Report 2024

About the Tetanus Vaccine Market